Erika Fiorino

Orbassano, 10043, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Implementation of a fully biodegradable and biomimetic epicardial patch providing synergic physico-chemical, mechanical and electrical cues for myocardial infarction therapy.

Implementation of a fully biodegradable and biomimetic epicardial patch providing synergic physico-chemical, mechanical and electrical cues for myocardial infarction therapy.

Journal: Biomaterials advances

Published: April 02, 2025

Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.

Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.

Journal: International journal of molecular sciences

Published: September 26, 2024

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.

Journal: Cancers

Published: October 04, 2023

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.

Journal: International journal of molecular sciences

Published: July 20, 2022

EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.

EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.

Journal: Cells

Published: September 03, 2021

Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models.

Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models.

Journal: Cancers

Published: December 26, 2020

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 30, 2020

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Journal: Oncoimmunology

Published: September 19, 2017

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.

Journal: Oncoimmunology

Published: September 01, 2017

Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.

Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 15, 2017

Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases.

Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases.

Journal: International journal of obesity (2005)

Published: February 24, 2016

HDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning.

HDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning.

Journal: Nature communications

Published: January 18, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026